Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better? Strickler, JH, Hanks, BA and Khasraw, Mustafa 2020, Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better?, Clinical Cancer Research, pp. 1-7, doi: 10.1158/1078-0432.ccr-20-3054. Attached Files Name Description MIMEType Size Downloads Title Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better? Author(s) Strickler, JH Hanks, BA Khasraw, Mustafa orcid.org/0000-0003-3249-9849 Journal name Clinical Cancer Research Start page 1 End page 7 Total pages 7 Publisher American Association for Cancer Research (AACR) Place of publication Philadelphia, Penn. Publication date 2020-11-16 ISSN 1078-0432 1557-3265 Notes in Press Language eng DOI 10.1158/1078-0432.ccr-20-3054 Indigenous content off Field of Research 1112 Oncology and Carcinogenesis HERDC Research category C1 Refereed article in a scholarly journal Persistent URL http://hdl.handle.net/10536/DRO/DU:30145547 Document type: Journal Article Collections: Faculty of Health School of Medicine Related Links Link Description Connect to published version Go to link with your DU access privileges     Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved. Versions Version Filter Type Fri, 20 Nov 2020, 07:54:05 EST Sat, 21 Nov 2020, 04:01:14 EST Sat, 16 Jan 2021, 05:12:10 EST Thu, 11 Feb 2021, 13:39:46 EST Thu, 11 Feb 2021, 13:42:25 EST Thu, 11 Feb 2021, 15:06:56 EST Filtered Full Citation counts:   Cited 0 times in TR Web of Science Cited 0 times in Scopus Search Google Scholar Access Statistics: 10 Abstract Views, 0 File Downloads  -  Detailed Statistics Created: Fri, 20 Nov 2020, 07:54:05 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.